IBM announced it is offering the IBM Db2 Developer Extension for Visual Studio (VS) Code—now generally available. Developers live in VS Code, but Db2 development often means switching tools to set up ...

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...